The Securities Commission has granted Bellus Health Inc. (the Filer) an order to cease being a reporting issuer. The decision is based on the following key points:
1. The Filer is not an OTC reporting issuer under specific regulations.
2. The Filer’s securities are owned by fewer than 15 security holders in each jurisdiction in Canada and less than 51 worldwide.
3. The Filer’s securities are not traded on any public marketplace or facility in Canada or elsewhere.
4. The Filer has requested to cease being a reporting issuer in all Canadian jurisdictions where it currently holds that status.
5. The Filer is not in violation of any securities legislation.
The decision was made in accordance with the Securities Act, R.S.O. 1990, c. S.5, as amended, specifically section 1(10)(a)(ii). The order reflects the consensus of the Decision Makers that the Filer meets the legislative criteria to cease being a reporting issuer.